The post Oracle and Baylor College Partner to Combat Alcohol-related Liver Disease appeared on BitcoinEthereumNews.com. Felix Pinkston Oct 23, 2025 19:48 Oracle Health and Baylor College of Medicine collaborate to enhance research on alcohol-related liver disease, leveraging AI and real-world data for improved diagnosis and treatment. Oracle Health and Life Sciences has announced a strategic collaboration with Baylor College of Medicine to advance research into alcohol-related liver disease (ALD), a growing public health concern in the United States. This partnership aims to harness state-of-the-art technology and data analytics to improve clinical insights and outcomes for patients affected by this condition. Leveraging AI and Real-World Data The collaboration will utilize Oracle Health’s AI data platform, which includes over 120 million longitudinal anonymized patient records. Baylor College of Medicine plans to expand its real-world data cohort to encompass more than one million patients. This significant dataset aims to facilitate earlier identification of ALD, enhance understanding of its progression, and inform more effective prevention and treatment strategies. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of early identification in altering disease outcomes. She highlighted the potential of combining Oracle’s robust data capabilities with Baylor’s expertise in clinical research and patient care to transform the study and treatment of ALD. Aiming for Transformative Clinical Insights Baylor College of Medicine intends to employ Oracle’s comprehensive datasets and AI tools to identify patterns, risk factors, and predictive markers in ALD progression. The collaboration aims to empower clinicians with actionable insights that can enhance patient care and inform public health strategies to mitigate ALD’s impact nationwide. Dr. Hashem El-Serag, Vice President for the Learning Health System Initiative at Baylor College of Medicine, expressed optimism about the partnership’s potential to accelerate discovery and improve clinical practice. He noted that building one of the largest ALD cohorts… The post Oracle and Baylor College Partner to Combat Alcohol-related Liver Disease appeared on BitcoinEthereumNews.com. Felix Pinkston Oct 23, 2025 19:48 Oracle Health and Baylor College of Medicine collaborate to enhance research on alcohol-related liver disease, leveraging AI and real-world data for improved diagnosis and treatment. Oracle Health and Life Sciences has announced a strategic collaboration with Baylor College of Medicine to advance research into alcohol-related liver disease (ALD), a growing public health concern in the United States. This partnership aims to harness state-of-the-art technology and data analytics to improve clinical insights and outcomes for patients affected by this condition. Leveraging AI and Real-World Data The collaboration will utilize Oracle Health’s AI data platform, which includes over 120 million longitudinal anonymized patient records. Baylor College of Medicine plans to expand its real-world data cohort to encompass more than one million patients. This significant dataset aims to facilitate earlier identification of ALD, enhance understanding of its progression, and inform more effective prevention and treatment strategies. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of early identification in altering disease outcomes. She highlighted the potential of combining Oracle’s robust data capabilities with Baylor’s expertise in clinical research and patient care to transform the study and treatment of ALD. Aiming for Transformative Clinical Insights Baylor College of Medicine intends to employ Oracle’s comprehensive datasets and AI tools to identify patterns, risk factors, and predictive markers in ALD progression. The collaboration aims to empower clinicians with actionable insights that can enhance patient care and inform public health strategies to mitigate ALD’s impact nationwide. Dr. Hashem El-Serag, Vice President for the Learning Health System Initiative at Baylor College of Medicine, expressed optimism about the partnership’s potential to accelerate discovery and improve clinical practice. He noted that building one of the largest ALD cohorts…

Oracle and Baylor College Partner to Combat Alcohol-related Liver Disease

2025/10/25 07:36
2분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다


Felix Pinkston
Oct 23, 2025 19:48

Oracle Health and Baylor College of Medicine collaborate to enhance research on alcohol-related liver disease, leveraging AI and real-world data for improved diagnosis and treatment.

Oracle Health and Life Sciences has announced a strategic collaboration with Baylor College of Medicine to advance research into alcohol-related liver disease (ALD), a growing public health concern in the United States. This partnership aims to harness state-of-the-art technology and data analytics to improve clinical insights and outcomes for patients affected by this condition.

Leveraging AI and Real-World Data

The collaboration will utilize Oracle Health’s AI data platform, which includes over 120 million longitudinal anonymized patient records. Baylor College of Medicine plans to expand its real-world data cohort to encompass more than one million patients. This significant dataset aims to facilitate earlier identification of ALD, enhance understanding of its progression, and inform more effective prevention and treatment strategies.

Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of early identification in altering disease outcomes. She highlighted the potential of combining Oracle’s robust data capabilities with Baylor’s expertise in clinical research and patient care to transform the study and treatment of ALD.

Aiming for Transformative Clinical Insights

Baylor College of Medicine intends to employ Oracle’s comprehensive datasets and AI tools to identify patterns, risk factors, and predictive markers in ALD progression. The collaboration aims to empower clinicians with actionable insights that can enhance patient care and inform public health strategies to mitigate ALD’s impact nationwide.

Dr. Hashem El-Serag, Vice President for the Learning Health System Initiative at Baylor College of Medicine, expressed optimism about the partnership’s potential to accelerate discovery and improve clinical practice. He noted that building one of the largest ALD cohorts in the country would create a valuable research resource and advance early intervention efforts for at-risk patients.

Addressing a Growing Health Challenge

According to recent studies, alcohol-related liver disease is increasingly prevalent in the U.S., particularly among younger populations. The collaboration between Oracle Health and Baylor College of Medicine seeks to address this urgent health challenge by combining advanced health technology with leading academic research.

For more information, visit the official announcement on Oracle’s website.

Image source: Shutterstock

Source: https://blockchain.news/news/oracle-baylor-college-combat-alcohol-liver-disease

시장 기회
플러리싱 에이아이 로고
플러리싱 에이아이 가격(SLEEPLESSAI)
$0.01817
$0.01817$0.01817
-3.70%
USD
플러리싱 에이아이 (SLEEPLESSAI) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

$30,000 in PRL + 15,000 USDT

$30,000 in PRL + 15,000 USDT$30,000 in PRL + 15,000 USDT

Deposit & trade PRL to boost your rewards!